541400 — Zim Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹4.50bn
- IN₹4.95bn
- IN₹3.99bn
- 65
- 39
- 35
- 41
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,354 | 2,777 | 3,073 | 3,334 | 3,985 |
Cost of Revenue | |||||
Gross Profit | 1,681 | 1,256 | 1,411 | 1,632 | 1,876 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,043 | 2,695 | 2,885 | 3,085 | 3,634 |
Operating Profit | 310 | 82.1 | 188 | 249 | 352 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 221 | 0.686 | 102 | 210 | 354 |
Provision for Income Taxes | |||||
Net Income After Taxes | 153 | 33 | 73.2 | 146 | 244 |
Net Income Before Extraordinary Items | |||||
Net Income | 153 | 33 | 73.2 | 146 | 244 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 153 | 33 | 73.2 | 146 | 244 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.63 | 2.03 | 6.79 | 8.96 | 5.11 |
Dividends per Share |